Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

NCT04368429 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Immunisation (Healthy Volunteers)

Interventions

BIOLOGICAL: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate Vaccine)
BIOLOGICAL: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Sponsor

Sanofi